Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Profit After Tax (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Profit After Tax for 13 consecutive years, with -$4.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 36.95% to -$4.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.7 million, a 3.22% decrease, with the full-year FY2025 number at -$11.7 million, down 3.22% from a year prior.
  • Profit After Tax was -$4.7 million for Q4 2025 at Ekso Bionics Holdings, down from -$1.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$1.3 million in Q2 2021 to a low of -$4.7 million in Q4 2025.
  • A 5-year average of -$3.2 million and a median of -$3.2 million in 2022 define the central range for Profit After Tax.
  • Biggest YoY gain for Profit After Tax was 89.18% in 2021; the steepest drop was 179.85% in 2021.
  • Ekso Bionics Holdings' Profit After Tax stood at -$2.9 million in 2021, then fell by 11.0% to -$3.2 million in 2022, then dropped by 1.13% to -$3.2 million in 2023, then dropped by 6.19% to -$3.4 million in 2024, then tumbled by 36.95% to -$4.7 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Profit After Tax are -$4.7 million (Q4 2025), -$1.4 million (Q3 2025), and -$2.7 million (Q2 2025).